The winning lot number of Shipu test was released: about 26300

Exclusive Interview with Zhou Mi, Managing Partner of Puhua Capital

“I entered the venture capital industry in 2008. I experienced the financial crisis in 2009 and the boom of the classical venture capital model from 2011 to 2015. Having experienced many ups and downs, I believe that venture capital will tide over the tough period and usher in new opportunities.”

Stem-cell Firm Hemacell Completes Pre-Series A+ Funding Round

Platelets play a crucial role in the coagulation process in vivo. However, platelets used in clinical practice mainly come from free donations and are in extreme shortage. Using stem cells to produce platelets in vitro is expected to solve this unmet clinical need.

InnoCare Pharma Gets Phase II Clinical Trial Approval for Monjuvi in China

It will be the first tafasitamab-based treatment for diffuse large B-cell lymphoma (DLBCL) in China if successful.

Meiling Biology & Medical Releases Solutions to Overcome Biological Security Problems

Meiling combines unique refrigeration expertise with IoT technology to provide global customers with safe, intelligent and efficient application scenarios

Sequoia-backed Radiation Therapy Full Life Nets USD 37 MN in Series A Funding

Founded in 2021, Full Life develops the platform to enhance the ability to produce high-quality and quantitative radioisotopes and to meet the unmet needs of radiopharmaceutical treatments.